Cargando…
Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells
BACKGROUND: Immune checkpoint inhibitors (ICI) have revolutionized the treatment for multiple cancers. However, most of patients encounter resistance. Synthetic viability (SV) between genes could induce resistance. In this study, we established SV signature to predict the efficacy of ICI treatment f...
Autores principales: | Liu, Mingyue, Dong, Qi, Chen, Bo, Liu, Kaidong, Zhao, Zhangxiang, Wang, Yuquan, Zhuang, Shuping, Han, Huiming, Shi, Xingyang, Jin, Zixin, Hui, Yang, Gu, Yunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575993/ https://www.ncbi.nlm.nih.gov/pubmed/37620409 http://dx.doi.org/10.1038/s41416-023-02404-w |
Ejemplares similares
-
Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome
por: Dong, Qi, et al.
Publicado: (2021) -
Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer
por: Li, Yawei, et al.
Publicado: (2021) -
A genetic map of the chromatin regulators to drug response in cancer cells
por: Chen, Bo, et al.
Publicado: (2022) -
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
por: Zhuang, Shuping, et al.
Publicado: (2021) -
An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering
por: Chen, Tingting, et al.
Publicado: (2020)